To date, no strong evidence of the clinical utility of biomarkers is available for Pv-SM even though some of them such as superoxide dismutase 1 (SOD), titin, vitronectin, TNF-α, and the Ang-2/1 ratio have shown interesting performances for the prognosis of malaria severity (Figure 6). This evidence concerns the gene ANGPT2 and malaria.